Jeffrey Embt
Patrimonio netto: 158 823 $ in data 31/05/2026
Patrimonio netto: 158 823 $ in data 31/05/2026
Mr. Jeffrey D.
Embt, CPA, is a Chief Accounting Officer at JELD-WEN Holding, Inc. Mr. Embt was previously employed as a Chief Accounting Officer by Proterra, Inc., a Chief Financial Officer by Proterra Operating Co., Inc., and a Head-Finance by BWXT Medical Ltd. He received his undergraduate degree from Coastal Carolina University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/02/2026 | 73.529 ( 0,09% ) | 158 823 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| JELD-WEN HOLDING, INC. | Comptroller/Controller/Auditor | 05/01/2026 |
| Società | Posizione | Fine |
|---|---|---|
Proterra Operating Co., Inc.
Proterra Operating Co., Inc. Auto Parts: OEMProducer Manufacturing Manufactures zero-emission electric powertrain transit solutions for medium and heavy duty commercial vehicles | Direttore Finanziario/CFO | 01/12/2025 |
| PROTERRA INC. | Comptroller/Controller/Auditor | 01/02/2024 |
BWXT Medical Ltd.
BWXT Medical Ltd. Part of BWX Technologies, Inc., BWXT Medical Ltd. is a Canadian company specializing in the development, manufacturing, and supply of advanced radiopharmaceutical products and medical isotopes for diagnostic imaging and targeted radiotherapeutic treatments. The company is based in Toronto, Canada. BWXT Medical offers a portfolio that includes isotopes such as actinium-225, germanium-68, indium-111, iodine-123, strontium-82, and technetium-99m generators, supporting clinical trials and patient treatments in more than 40 countries. The company produces radiochemicals, APIs, radiopharmaceutical unit doses, and automation solutions in a cGMP/GLP facility, and provides contract manufacturing for products like TheraSphere™ for liver cancer treatment. BWXT Medical collaborates with partners such as TRIUMF, Bayer AG, and Fusion Pharmaceuticals to advance nuclear medicine technologies and participates in organizations supporting the medical isotope sector. The CEO of the company is Jonathan W. Cirtain. | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Proterra Operating Co., Inc.
Proterra Operating Co., Inc. Auto Parts: OEMProducer Manufacturing Manufactures zero-emission electric powertrain transit solutions for medium and heavy duty commercial vehicles | Producer Manufacturing |
Coastal Carolina University
Coastal Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JELD-WEN Holding, Inc.
JELD-WEN Holding, Inc. Forest ProductsNon-Energy Minerals Manufactures doors, windows and related products | Non-Energy Minerals |
BWXT Medical Ltd.
BWXT Medical Ltd. Part of BWX Technologies, Inc., BWXT Medical Ltd. is a Canadian company specializing in the development, manufacturing, and supply of advanced radiopharmaceutical products and medical isotopes for diagnostic imaging and targeted radiotherapeutic treatments. The company is based in Toronto, Canada. BWXT Medical offers a portfolio that includes isotopes such as actinium-225, germanium-68, indium-111, iodine-123, strontium-82, and technetium-99m generators, supporting clinical trials and patient treatments in more than 40 countries. The company produces radiochemicals, APIs, radiopharmaceutical unit doses, and automation solutions in a cGMP/GLP facility, and provides contract manufacturing for products like TheraSphere™ for liver cancer treatment. BWXT Medical collaborates with partners such as TRIUMF, Bayer AG, and Fusion Pharmaceuticals to advance nuclear medicine technologies and participates in organizations supporting the medical isotope sector. The CEO of the company is Jonathan W. Cirtain. | |
Proterra, Inc.
Proterra, Inc. Motor VehiclesConsumer Durables Designs and manufactures zero-emission electric transit vehicles | Consumer Durables |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale